Company profile
SES Solar Inc.
OTC: SESI · Healthcare · Drug Manufacturers - Specialty & Generic
PublicHQ Plan-les-Ouates, FLReports USD
#1161 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
——FH —DQ —GM —SS 34
v0.1 · 5/100 weight · pillars only
↑ Piotroski F, listing tenure · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$5.5M
Rev growth YoY (TTM)
+324.6%
Net income (FY)
-$15.9k
Employees
4
as of 2026-07-19
Market cap
$7.3k
as of 2026-07-19
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02019
Net income-$15.9k-$15.9k2019
Operating income-$14.8k-$14.8k2019
Total assets$14.1k$14.1k2019
Liabilities$234.9k$234.9k2019
Equity-$220.9k-$220.9k2019
Revenue trend
FY2004 – FY2019 · USD
FY04
FY06
FY07
FY08
FY09
FY19
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is SES Solar Inc.’s revenue?
SES Solar Inc. booked $0 in FY2019 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
RenovaCare, Inc.——Ceres Ventures, Inc.——HTC Purenergy Inc.——Nexien BioPharma, Inc.——FluoroPharma Medical, Inc.——PAO Group, Inc.——Key facts
CEOReut Susan
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersPlan-les-Ouates, FL
ExchangeOTC: SESI
Employees4
IPO date2006-01-04
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.